Recruiting Lymphoma Studies in Villejuif
A Phase 1/2 Study of STP938 for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas
The Phase 1 part of the study is a dose escalation of STP938 as monotherapy. The Phase 2 part of the study is cohort expansion of STP938 as a monotherapy in 5 different B and T cell lymphomas....
AZD3470 as Monotherapy and in Combination With Anticancer Agents in Participants With Relapsed/Refractory Haematologic Malignancies.
This study is designed to evaluate the safety, tolerability, PK and preliminary efficacy following oral administration of AZD3470 as a monotherapy, and in combination with other anticancer agents in p...
About Lymphoma Clinical Trials in Villejuif
Lymphoma is a cancer of the lymphatic system that affects infection-fighting cells called lymphocytes. The two main types are Hodgkin lymphoma and non-Hodgkin lymphoma. Treatment often includes chemotherapy, radiation, immunotherapy, and in some cases stem cell transplant.
There are currently 2 lymphoma clinical trials recruiting participants in Villejuif, . These studies are seeking a combined 290 participants. Research is being sponsored by Step Pharma, SAS, AstraZeneca. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lymphoma Clinical Trials in Villejuif — FAQ
Are there lymphoma clinical trials in Villejuif?
Yes, there are 2 lymphoma clinical trials currently recruiting in Villejuif, . Browse the studies on this page to find one that fits.
How do I join a clinical trial in Villejuif?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Villejuif research site will contact you about next steps.
Are clinical trials in Villejuif free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Villejuif studies also compensate for your time and travel.
What lymphoma treatments are being tested?
The 2 active trials in Villejuif are testing new therapies including novel drugs, biologics, and treatment approaches for lymphoma.
Data updated March 2, 2026 from ClinicalTrials.gov